Department of Pathology, Université Paris Cité, Hôpitaux Necker-Enfants Malades et Robert Debré, APHP, INSERM, U1163, Institut IMAGINE, Paris, France.
Department of Pathology and Laboratory Medicine, Mayo Clinic, Rochester, MN, USA.
Lung Cancer. 2024 Mar;189:107479. doi: 10.1016/j.lungcan.2024.107479. Epub 2024 Jan 24.
Pathologists are staging thymic epithelial tumors (TET) according to the 8th UICC/AJCC TNM system. Within the French RYTHMIC network, dedicated to TET, agreement on pathologic tumor stage (pT) among the pathology panelists was difficult. The aim of our study was to determine the interobserver reproducibility of pT at an international level, to explore the source of discrepancies and potential interventions to address these.
An international panel of pathologists was recruited through the International Thymic Malignancy Interest Group (ITMIG). The study focused on invasion of mediastinal pleura, pericardium, and lung. From a cohort of cases identified as challenging within the RYTHMIC network, we chose a series of test and validation cases (n = 5 and 10, respectively).
Reproducibility of the pT stage was also challenging at an international level as none of the 15 cases was classified as the same pT stage by all ITMIG pathologists. The agreement rose from slight (κ = 0.13) to moderate (κ = 0.48) between test and validation series. Discussion among the expert pathologists pinpointed two major reasons underlying discrepancies: 1) Thymomas growing with their "capsule" and adhering to the pleurae, pericardium, or lung were often misinterpreted as invading these structures. 2) Recognition of the mediastinal pleura was identified as challenging.
Our study underlines that the evaluation of the pT stage of TET is problematic and needs to be addressed in more detail in an upcoming TNM classification. The publication of histopathologic images of landmarks, including ancillary tests could improve reproducibility for future TNM classifications.
病理学家根据第 8 版 UICC/AJCC TNM 系统对胸腺癌上皮肿瘤(TET)进行分期。在专门研究 TET 的法国 RYTHMIC 网络中,病理学家小组对病理肿瘤分期(pT)的意见难以达成一致。本研究的目的是确定国际上 pT 的观察者间可重复性,探讨差异的来源以及解决这些问题的潜在干预措施。
通过国际胸腺癌兴趣小组(ITMIG)招募了一个国际病理学家小组。该研究集中在侵袭纵隔胸膜、心包和肺。从 RYTHMIC 网络中确定为具有挑战性的病例队列中,我们选择了一系列测试和验证病例(分别为 5 例和 10 例)。
国际层面的 pT 分期也具有挑战性,因为没有一例 15 例病例被所有 ITMIG 病理学家归类为相同的 pT 分期。测试和验证系列之间的一致性从轻微(κ=0.13)上升到中度(κ=0.48)。专家病理学家之间的讨论指出了导致差异的两个主要原因:1)胸腺瘤随其“包膜”生长并附着于胸膜、心包或肺,常被误诊为侵犯这些结构。2)纵隔胸膜的识别被认为具有挑战性。
本研究强调,TET 的 pT 分期评估存在问题,需要在即将到来的 TNM 分类中更详细地解决。发布包括辅助检查在内的地标组织病理学图像可以提高未来 TNM 分类的可重复性。